Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Every day, millions of people around the world inject insulin subcutaneously
While primarily studied in animal models, emerging clinical data and its use in compounding pharmacies highlight its promise for conditions ranging from musculoskeletal injuries to gastrointestinal disorders
Many insurers will cover these injections when prescribed by our healthcare providers to treat a diagnosed vitamin B12 deficiency or related conditions such as pernicious anemia, gastrointestinal issues affecting nutrient absorption, or certain neurological disorders
By flagging it in Category 2, FDA signaled to pharmacies that BPC-157 is not permitted to be compounded under federal law (Section 503A) due to these safety uncertainties
The choice depends on several factors, such as the injection dose, frequency, and medical equipment
We encourage you to consult with our healthcare professionals before starting any supplementation to ensure the right dosage for your individual needs
